rs1550094

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001195129.2(PRSS56):​c.88G>A​(p.Ala30Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.694 in 1,530,984 control chromosomes in the GnomAD database, including 371,791 homozygotes. In-silico tool predicts a benign outcome for this variant. 9/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.65 ( 32965 hom., cov: 32)
Exomes 𝑓: 0.70 ( 338826 hom. )

Consequence

PRSS56
NM_001195129.2 missense

Scores

1
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.922

Publications

38 publications found
Variant links:
Genes affected
PRSS56 (HGNC:39433): (serine protease 56) This gene encodes a protein that contains a peptidase S1 domain and possesses trypsin-like serine protease activity. The encoded protein may play a role in eye development, and mutations in this gene are a cause of autosomal recessive posterior microphthalmos. [provided by RefSeq, Dec 2011]
PRSS56 Gene-Disease associations (from GenCC):
  • isolated microphthalmia 6
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
  • nanophthalmia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=5.478455E-7).
BP6
Variant 2-232520686-G-A is Benign according to our data. Variant chr2-232520686-G-A is described in ClinVar as Benign. ClinVar VariationId is 677180.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.879 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRSS56NM_001195129.2 linkc.88G>A p.Ala30Thr missense_variant Exon 1 of 13 ENST00000617714.2 NP_001182058.1 P0CW18
PRSS56NM_001369848.1 linkc.88G>A p.Ala30Thr missense_variant Exon 1 of 13 NP_001356777.1
PRSS56XM_047445431.1 linkc.88G>A p.Ala30Thr missense_variant Exon 1 of 12 XP_047301387.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRSS56ENST00000617714.2 linkc.88G>A p.Ala30Thr missense_variant Exon 1 of 13 5 NM_001195129.2 ENSP00000479745.1 P0CW18

Frequencies

GnomAD3 genomes
AF:
0.648
AC:
98494
AN:
151898
Hom.:
32938
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.484
Gnomad AMI
AF:
0.586
Gnomad AMR
AF:
0.707
Gnomad ASJ
AF:
0.687
Gnomad EAS
AF:
0.901
Gnomad SAS
AF:
0.698
Gnomad FIN
AF:
0.763
Gnomad MID
AF:
0.636
Gnomad NFE
AF:
0.694
Gnomad OTH
AF:
0.622
GnomAD2 exomes
AF:
0.717
AC:
95950
AN:
133744
AF XY:
0.714
show subpopulations
Gnomad AFR exome
AF:
0.470
Gnomad AMR exome
AF:
0.785
Gnomad ASJ exome
AF:
0.699
Gnomad EAS exome
AF:
0.899
Gnomad FIN exome
AF:
0.752
Gnomad NFE exome
AF:
0.695
Gnomad OTH exome
AF:
0.693
GnomAD4 exome
AF:
0.699
AC:
963286
AN:
1378968
Hom.:
338826
Cov.:
33
AF XY:
0.699
AC XY:
475195
AN XY:
680082
show subpopulations
African (AFR)
AF:
0.472
AC:
14872
AN:
31490
American (AMR)
AF:
0.775
AC:
27623
AN:
35630
Ashkenazi Jewish (ASJ)
AF:
0.696
AC:
17463
AN:
25096
East Asian (EAS)
AF:
0.875
AC:
31187
AN:
35654
South Asian (SAS)
AF:
0.688
AC:
54461
AN:
79102
European-Finnish (FIN)
AF:
0.757
AC:
25631
AN:
33868
Middle Eastern (MID)
AF:
0.620
AC:
3513
AN:
5668
European-Non Finnish (NFE)
AF:
0.697
AC:
748627
AN:
1074770
Other (OTH)
AF:
0.692
AC:
39909
AN:
57690
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
13356
26712
40068
53424
66780
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19250
38500
57750
77000
96250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.648
AC:
98559
AN:
152016
Hom.:
32965
Cov.:
32
AF XY:
0.655
AC XY:
48679
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.484
AC:
20065
AN:
41440
American (AMR)
AF:
0.707
AC:
10814
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.687
AC:
2386
AN:
3472
East Asian (EAS)
AF:
0.901
AC:
4645
AN:
5158
South Asian (SAS)
AF:
0.698
AC:
3364
AN:
4818
European-Finnish (FIN)
AF:
0.763
AC:
8075
AN:
10582
Middle Eastern (MID)
AF:
0.636
AC:
187
AN:
294
European-Non Finnish (NFE)
AF:
0.694
AC:
47169
AN:
67942
Other (OTH)
AF:
0.626
AC:
1322
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1698
3396
5095
6793
8491
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
792
1584
2376
3168
3960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.689
Hom.:
75029
Bravo
AF:
0.640
TwinsUK
AF:
0.706
AC:
2616
ALSPAC
AF:
0.708
AC:
2729
ExAC
AF:
0.609
AC:
10624
Asia WGS
AF:
0.754
AC:
2621
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Isolated microphthalmia 6 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 22, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.057
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
16
DANN
Benign
0.88
DEOGEN2
Benign
0.0041
T;T
FATHMM_MKL
Benign
0.049
N
LIST_S2
Benign
0.18
T;T
MetaRNN
Benign
5.5e-7
T;T
MutationAssessor
Benign
-0.34
.;N
PhyloP100
0.92
PrimateAI
Uncertain
0.51
T
Sift4G
Benign
1.0
T;T
Vest4
0.029
GERP RS
2.3
PromoterAI
-0.020
Neutral
Varity_R
0.039
gMVP
0.28
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1550094; hg19: chr2-233385396; COSMIC: COSV71930103; COSMIC: COSV71930103; API